Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts
2019
Brain membrane lipids in major depression and anxiety disorders
2014
Atherosclerotic Renal Artery Stenosis
2002 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
The impact of atherosclerotic renovascular disease on diabetic renal failure
2002
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Changes in Lipidome Composition during Brain Development in Humans, Chimpanzees, and Macaque Monkeys
2017 StandoutNobel
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Renal-Artery Stenosis
2001 Standout
Progression of renal artery stenosis in patients undergoing cardiac catheterization
1998
Drug-induced acute kidney injury
2005
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
2009 Standout
A strategy to reduce cardiovascular disease by more than 80%
2003 Standout
Cardiovascular Outcomes and All-Cause Mortality: Exploring the Interaction Between CKD and Cardiovascular Disease
2006
Management of Abdominal Aortic Aneurysms Clinical Practice Guidelines of the European Society for Vascular Surgery
2011 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Pharmacotherapy of Pompe disease
2013
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis
2010
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
2013 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy
2003
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of S. Waldek being referenced
A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease
2002
Increasing the diagnostic yield of renal angiography for the diagnosis of atheromatous renovascular disease
2001
Renovascular Disease and Renal Complications of Angiotensin-Converting Enzyme Inhibitor Therapy
1990
Fabry disease: a review of current management strategies
2010
Depression in adults with Fabry disease: A common and under‐diagnosed problem
2007
The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders.
2012
Long‐term effectiveness of enzyme replacement therapy in Fabry disease: results from the NCS‐LSD cohort study
2014